Accelerating the Development of Biologic Therapeutics through Advanced Analytics
BioAnalytix is developing and applying advanced analytic methods and data to enable, improve and accelerate biologic therapeutics from development through market
What We Do
BioAnalytix is a pharmaceutically oriented spin-out from the Barnett Institute of Chemical and Biological Analysis at Northeastern University. Founded in 2012 by thought leaders in biologic drug development, regulatory strategy, and advanced analytics, BioAnalytix works with leading pharmaceutical companies to develop and apply advanced analytic technologies, methods and data in enabling, improving and accelerating biologic therapeutics from development through market.
BioAnalytix Partners with Northeastern University and the Barnett Institute to Host the Inaugural Advanced Biologic Development Summit at Northeastern University on October 9, 2018
BioAnalytix Joins with Lead Pharma to Publish New Review Article: Analytical Comparability Study of mAbs
mAbs – (May/June - 2018)